Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-02-01 Sale |
2021-02-03 11:24 am |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $34.35 | $75,572 | 248,338 (Indirect Direct) |
View |
2021-02-01 Sale |
2021-02-03 11:23 am |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
5,000 | $35 | $175,000 | 161,395 (Indirect Direct) |
View |
2021-01-29 Sale |
2021-02-02 7:39 pm |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
10,000 | $33.22 | $332,207 | 941,372 (Indirect Direct) |
View |
2021-01-19 Sale |
2021-01-21 4:41 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,750 | $30 | $52,500 | 166,395 (Indirect Direct) |
View |
2021-01-05 Sale(A) |
2021-01-07 3:13 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
10,000 | $28.08 | $280,754 | 924,452 (Indirect Direct) |
View |
2020-09-29 Sale |
2021-01-07 2:39 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $30 | $90,000 | 933,057 (Indirect Direct) |
View |
2021-01-04 Sale |
2021-01-06 1:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $27.82 | $61,215 | 249,316 (Indirect Direct) |
View |
2020-12-14 Sale |
2020-12-16 3:15 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
15,000 | $30 | $450,000 | 375,489 (Indirect Direct) |
View |
2020-12-14 Sale |
2020-12-16 3:14 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
5,250 | $30 | $157,500 | 168,145 (Indirect Direct) |
View |
2020-12-01 Sale |
2020-12-03 7:40 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $25.98 | $57,155 | 249,464 (Indirect Direct) |
View |
2020-11-02 Sale |
2020-11-04 4:33 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $18.27 | $40,186 | 250,442 (Indirect Direct) |
View |
2020-10-02 Purchase |
2020-10-06 5:27 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner |
496,000 | $25 | $12,400,000 | 902,286 (Indirect) |
View |
2020-10-02 Purchase |
2020-10-06 5:23 pm |
Arcutis Biotherapeutics Inc. | ARQT | SILVERSTEIN JONATHAN Director 10% Owner |
496,000 | $25 | $12,400,000 | 902,286 (Indirect) |
View |
2020-10-01 Sale |
2020-10-05 9:13 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $27.65 | $60,829 | 251,420 (Indirect Direct) |
View |
2020-09-01 Sale(A) |
2020-10-05 9:12 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $24.38 | $53,643 | 252,398 (Indirect Direct) |
View |
2020-09-29 Sale |
2020-10-01 9:02 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $30 | $90,000 | 933,057 (Indirect Direct) |
View |
2020-09-29 Sale |
2020-10-01 9:01 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
15,000 | $30 | $450,000 | 389,235 (Indirect Direct) |
View |
2020-09-29 Sale |
2020-10-01 9:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,750 | $30 | $52,500 | 172,072 (Indirect Direct) |
View |
2020-09-01 Sale |
2020-09-02 11:48 am |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $24.38 | $53,643 | 214,979 (Indirect Direct) |
View |
2020-08-03 Sale |
2020-08-05 5:11 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,800 | $25.63 | $71,764 | 238,412 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-02-04 Exercise |
2021-02-08 1:45 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
19,861 | $0 | 266,758 (Direct) |
View |
2021-02-04 Exercise |
2021-02-08 1:45 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
19,861 | $1.6806 | 266,758 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 11:24 am |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 248,338 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 11:24 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.6806 | 248,338 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 11:23 am |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,250 | $0 | 161,395 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 11:23 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,250 | $1.6806 | 161,395 (Direct) |
View |
2021-01-19 Option Award |
2021-01-21 8:07 pm |
N/A 2031-01-19 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
160,000 | $0 | 160,000 (Direct) |
View |
2021-01-19 Exercise |
2021-01-21 4:41 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $0 | 166,395 (Direct) |
View |
2021-01-19 Exercise |
2021-01-21 4:41 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $1.6806 | 166,395 (Direct) |
View |
2021-01-12 Exercise |
2021-01-14 11:11 am |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 232,549 (Direct) |
View |
2021-01-12 Exercise |
2021-01-14 11:11 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 232,549 (Direct) |
View |
2021-01-05 Exercise(A) |
2021-01-07 3:13 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
10,000 | $0 | 924,452 (Direct) |
View |
2021-01-05 Exercise(A) |
2021-01-07 3:13 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
10,000 | $1.6806 | 924,452 (Direct) |
View |
2020-09-29 Exercise |
2021-01-07 2:39 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $0 | 933,057 (Direct) |
View |
2020-09-29 Exercise |
2021-01-07 2:39 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $1.6806 | 933,057 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 1:16 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 249,316 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 1:16 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.6806 | 249,316 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,500 | $0 | 168,145 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
1,500 | $1.6806 | 168,145 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 232,549 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 3:14 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 232,549 (Direct) |
View |
2020-12-01 Exercise |
2020-12-03 7:40 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 249,464 (Direct) |
View |
2020-12-01 Exercise |
2020-12-03 7:40 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 249,464 (Direct) |
View |
2020-11-12 Exercise |
2020-11-13 11:57 am |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 231,719 (Direct) |
View |
2020-11-12 Exercise |
2020-11-13 11:57 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 231,719 (Direct) |
View |
2020-11-02 Option Award |
2020-11-04 4:34 pm |
N/A 2030-11-02 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
37,500 | $0 | 37,500 (Direct) |
View |
2020-11-02 Exercise |
2020-11-04 4:33 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 250,442 (Direct) |
View |
2020-11-02 Exercise |
2020-11-04 4:33 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 250,442 (Direct) |
View |
2020-10-26 Exercise |
2020-10-27 2:03 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,668 | $6.52 | 168,943 (Direct) |
View |
2020-10-26 Exercise |
2020-10-27 2:03 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,668 | $0 | 168,943 (Direct) |
View |
2020-10-22 Exercise |
2020-10-23 1:27 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,695 | $6.52 | 168,943 (Direct) |
View |
2020-10-22 Exercise |
2020-10-23 1:27 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,695 | $0 | 168,943 (Direct) |
View |
2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
7,500 | $6.52 | 168,943 (Direct) |
View |
2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
7,500 | $0 | 168,943 (Direct) |
View |
2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 231,719 (Direct) |
View |
2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 231,719 (Direct) |
View |
2020-10-01 Exercise |
2020-10-05 9:13 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 251,420 (Direct) |
View |
2020-10-01 Exercise |
2020-10-05 9:13 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 251,420 (Direct) |
View |
2020-09-01 Exercise(A) |
2020-10-05 9:12 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 252,398 (Direct) |
View |
2020-09-01 Exercise(A) |
2020-10-05 9:12 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 252,398 (Direct) |
View |
2020-09-29 Exercise |
2020-10-01 9:02 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $0 | 933,057 (Direct) |
View |
2020-09-29 Exercise |
2020-10-01 9:02 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,000 | $1.6806 | 933,057 (Direct) |
View |
2020-09-29 Exercise |
2020-10-01 9:00 pm |
N/A 2029-05-14 |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $0 | 172,072 (Direct) |
View |
2020-09-29 Exercise |
2020-10-01 9:00 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer |
500 | $1.6806 | 172,072 (Direct) |
View |
2020-09-15 Exercise |
2020-09-16 5:57 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0 | 231,719 (Direct) |
View |
2020-09-15 Exercise |
2020-09-16 5:57 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,222 | $0.5802 | 231,719 (Direct) |
View |
2020-09-01 Exercise |
2020-09-02 11:48 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $1.68 | 214,979 (Direct) |
View |
2020-09-01 Exercise |
2020-09-02 11:48 am |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,200 | $0 | 214,979 (Direct) |
View |
2020-08-20 Exercise |
2020-08-21 2:19 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,000 | $1.68 | 246,151 (Direct) |
View |
2020-08-20 Exercise |
2020-08-21 2:19 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,000 | $0 | 246,151 (Direct) |
View |
2020-08-18 Exercise |
2020-08-19 5:48 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,076 | $1.68 | 209,836 (Direct) |
View |
2020-08-18 Exercise |
2020-08-19 5:48 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,076 | $0 | 209,836 (Direct) |
View |
2020-08-14 Exercise |
2020-08-18 4:12 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,110 | $0 | 221,643 (Direct) |
View |
2020-08-14 Exercise |
2020-08-18 4:12 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,110 | $0.5802 | 221,643 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 5:11 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,800 | $1.68 | 238,412 (Direct) |
View |
2020-08-03 Exercise |
2020-08-05 5:11 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,800 | $0 | 238,412 (Direct) |
View |
2020-08-03 Option Award |
2020-08-05 5:02 pm |
N/A 2030-08-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
353,500 | $0 | 353,500 (Direct) |
View |